Patent · US Active

Bispecific signaling agents and uses thereof

US10988538B2 · kind B2 · utility

4Cited by

4References

45Claims

0Family size

Assignees

Orionis Biosciences, Inc · US
VIB VZW · BE
UNIVERSITEIT GENT · BE

Inventors

Nikolai KLEY · Waltham, US
Jan Tavernier · Balegem, BE
Sandra VAN LINT · Wolvertem, BE
Anje CAUWELS · Merelbeke, BE

Key dates

Filing date	Feb 6, 2017
Grant date	Apr 27, 2021
Priority date	—
Expiry date	May 27, 2037

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in part, to bispecific chimeric proteins that find use in various immunotherapies based on various properties, including, for example, a dual immune cell recruitment and immune signal delivery function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.